References
1) Deacock, S. (2008). An approach to the patient with
urticaria. Clinical & Experimental Immunology, 153(2), pp.151-161.
2) Fröhlich, E. and Wahl, R. (2017). Thyroid Autoimmunity: Role of
Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.
Frontiers in Immunology, 8.
3) Kravets, I. (2016). Hyperthyroidism: Diagnosis and Treatment.
American Family Physician, 93(5), pp.1-2.
4) Isaacs, N. and Ertel, N. (1971). Urticaria and pruritus: Uncommon
manifestations of hyperthyroidism. Journal of Allergy and Clinical
Immunology, 48(2), pp.73-81.
5) Lee, S., Ha, E., Jee, H., Lee, K., Lee, S., Kim, M., Kim, D., Jung,
Y., Sheen, Y., Sung, M. and Han, M. (2017). Prevalence and Risk Factors
of Urticaria With a Focus on Chronic Urticaria in Children. Allergy,
Asthma & Immunology Research, 9(3), p.212.
6) O’Donnell, B., Lawlor, F., Simpson, J., Morgan, M. and Greaves, M.
(1997). The impact of chronic urticaria on the quality of life. British
Journal of Dermatology, 136(2), pp.197-201.
7) Baiardini, I., Pasquali, M., Braido, F., Fumagalli, F., Guerra, L.,
Compalati, E., Braga, M., Lombardi, C., Fassio, O. and Canonica, G.
(2005). A new tool to evaluate the impact of chronic urticaria on
quality of life: chronic urticaria quality of life questionnaire
(CU-Q2oL). Allergy, 60(8), pp.1073-1078.
8) Cks.nice.org.uk. (2019). Urticaria - NICE CKS. [online] Available
at: https://cks.nice.org.uk/urticaria#!scenario [Accessed 20 Jul.
2019].
9) Rothfeld, B. (1968). Pruritus as a Symptom in Hyperthyroidism. JAMA:
The Journal of the American Medical Association, 205(1), p.52.
10) Selvendran, S. and Aggarwal, N. (2018). Chronic urticaria and
thyroid autoimmunity: a perplexing association. Oxford Medical Case
Reports, 2018(2).
11) Altrichter, S., Peter, H., Pisarevskaja, D., Metz, M., Martus, P.
and Maurer, M. (2011). IgE Mediated Autoallergy against Thyroid
Peroxidase – A Novel Pathomechanism of Chronic Spontaneous
Urticaria?. PLoS ONE, 6(4), p.e14794.
12) Metz, M., Staubach, P., Bauer, A., Brehler, R., Gericke, J., Kangas,
M., Ashton-Chess, J., Jarvis, P., Georgiou, P., Canvin, J., Hillenbrand,
R., Erpenbeck, V. and Maurer, M. (2017). Clinical efficacy of omalizumab
in chronic spontaneous urticaria is associated with a reduction of
FcεRI-positive cells in the skin. Theranostics, 7(5), pp.1266-1276.
13) Abraham, P. and Acharya (2009). Current and emerging treatment
options for Graves’ hyperthyroidism. Therapeutics and Clinical Risk
Management, p.29.
14) Brent, G. (2012). Mechanisms of thyroid hormone action. Journal of
Clinical Investigation, 122(9), pp.3035-3043.
15) Ponmani, C., Mcclatchey, M., Kanzaria, S., Keane, M. and Banerjee,
K. (2014). Severe Urticaria in Graves’ Disease: is Carbimazole to
Blame?. Hormone Research in Paediatrics, [online] 82(P-D-2-2-599).
Available at: http://abstracts.eurospe.org/hrp/0082/hrp0082p2-d2-599
[Accessed 20 Jul. 2019].
16) Pan, S., Wood, D. and Chatterjee, K. (2012). Fixed drug eruption in
the endocrine clinic: rare presentation of reaction to
carbimazole. Endocrine Abstracts, [online] 28(P367). Available at:
https://www.endocrine-abstracts.org/ea/0028/ea0028p367 [Accessed 20
Jul. 2019].
17) Pearce, S. (2004). Spontaneous reporting of adverse reactions to
carbimazole and propylthiouracil in the UK. Clinical Endocrinology,
61(5), pp.589-594.
18) Demir, M., Yaylaci, S., Tamer, A. and Ayturk, S. (2013).
Propylthiouracil induced leukocytoclastic vasculitis: A rare
manifestation. Indian Journal of Endocrinology and Metabolism, 17(2),
p.339.
19) Talapatra, I., Prabhakar, K. and Tymms, D. (2007). Urticaria; An
Uncommon Presentation Of Thyrotoxicosis. European Journal of General
Medicine, 4(4), pp.205-208.